nova

Atkins Product Innovations for Weight Wellness

By acknowledging the feelings of isolation and frustrations that many experience, Atkins Way offers a better way, providing freedom from a lifetime of dieting through a joyful approach to eating, says the brand. 




nova

Chunk Foods Showcases New Innovations at The National Restaurant Association Show

The company had a new product on hand, which was a large slab of plant-based meat; and a cubed product specifically geared toward fast-casual restaurants. 




nova

Plant-Based Innovations: Califia, Milkadamia, and More Expand Beverage and Creamer Offerings

“Given the success of our Matcha Almond Latte, we’ve expanded our line of tea beverages with Chai Almond Latte based on the growing popularity of chai tea lattes and consumer demand for easy solutions for café favorites at home,” said Suzanne Ginestro, Califia’s chief marketing officer.




nova

Flooring Sector Invests in Future: Training, Partnerships, and Installation Innovation Take Center Stage

The industry is preparing for 2025 with a focus on improving installation processes and attracting new talent. Initiatives include Mohawk's CFI certification for product development teams, IFC's partnership with FCEF for workforce development, and various educational programs. 




nova

Completing an Employee-focused Design-Build Renovation for Crown Bakeries

The company successfully completed a build-out with employee-centered construction for Crown Bakeries.




nova

Mohawk Builder Multifamily Hosts Design Summit, Showcasing Innovation and Sustainability in Flooring

Mohawk Builder Multifamily welcomed 11 designers from across the country to its inaugural design summit in Alpharetta, Georgia, to build relationships, garner feedback on flooring products in development, and share insights about the company's investments in innovation and sustainability.




nova

Bathroom Renovations Reflect Changing Homeowner Priorities

Homeowners are shifting their approach to bathroom renovations with personal comfort and long-term usability increasingly prioritized over resale value considerations.




nova

Novalis CEO John Wu on Resilient Flooring Industry Trends and Strategic Growth in 2024

Learn how this leader in resilient flooring emphasizes long-term planning, approaches the evolving role of digital printing, and discusses the importance of clear product storytelling. Plus, Wu highlights Novalis' commitment to domestic manufacturing.




nova

Shaping the Future of Flooring Through Collaboration and Innovation

Get an inside look at the art of flooring design through the eyes of Audra Keiber, Mohawk’s director of design & development. In this episode, Keiber gives us a behind-the-scenes look at the Mohawk Design Summit, bringing retailers and designers together to forecast 2025 and 2026 trends and product ideation.




nova

2018 Plant Construction Survey: Rising Rate of Food & Beverage Plant Renovations/Expansions

Food Engineering's 41st annual Plant Construction Survey reveals that the ratio of the number of plant renovations and expansions versus new, greenfield projects has again risen from last year, indicating several owners and operators are trying to stay put.




nova

NFA Spring 2024 Vendor Day Highlights: Innovations and Promotions Aimed to Drive Flooring Sales

The National Floorcovering Alliance's 26 vendor partners came armed with new products and promotion ideas aimed to boost sales for flooring retailers in 2024. 




nova

Cobo Renovation Perfect Venue To Showcase Beauty, Versatility of Large, Thin Tiles

Since its opening in 1960, Detroit’s Cobo Center has become one of the country’s most famous venues, drawing visitors to the banks of the Detroit River for the nation’s premier auto shows, concerts, political conventions and an endless variety of other events.




nova

Shaw Creates ‘Living Lab’ to Test Product Innovations

Nine furnished apartments featuring Shaw products will house young professionals going through training in Dalton, Ga., and to assess product performance, user experience and the latest design trends.




nova

Partnerships, Innovations, On-Trend Finishes Drive Commercial Flooring Sales for Bjelin

From NeoCon 2024, Bjelin U.S. General Manager Zach Adams shares insights into what's driving wood flooring sales in the commercial market and the manufacturer's new partnership with Spartan Surfaces. 




nova

Riva Spain Partners with the University of Miami for Innovative Design Studio

The three-year program, led by Professors Shawna and Chris Meyer, will offer architecture students hands-on experience in material innovation. 




nova

Cali Marks 20 Years of Coastal-Inspired Home Innovation with Anniversary Sale

The company, which started in 2024 with two college friends' idea to create sustainable building materials from bamboo after a surf trip to Hawaii, has grown into a diverse brand offering premium flooring, rugs, turf, and composite decking.




nova

Innovation drives success in food safety

It is imperative that food processors understand that innovation is an imperative, and a failure to innovate can mean that they will begin to fall behind their competitors.




nova

Looking for innovative solutions

Food and beverage processors look for new ways to improve operations while facing the ongoing challenges of the COVID-19 pandemic.




nova

Plant of the Year Submissions Show Innovation Abounds

What Keurig Dr Pepper and Cuisine Solutions—and the other submissions we received for this year's Engineering Plant of the Year and Sustainable Plant of the Year award—do have in common is the level of innovation and creative solutions present throughout the plants.




nova

Domotex 2023 Showcases Sustainability, Innovation and Color

Floor Trends reports on the latest flooring technologies and sustainable initiatives from Domotex in Hannover, Germany. 




nova

Discover the 2023 Innovations in Profiles, Stair Treads and Transitions

The newest flooring accessories for 2023 check all the boxes: they are great looking, easier to install, and have better functionality than ever before. 




nova

Performance Accessories Provides New Innovations and Upgraded Digital Experience

Performance Accessories offers a total system of industry-leading flooring solutions — including trims and transitions, stair solutions, adhesives, underlayments and cleaners — designed to complement and complete any flooring installation. 




nova

Innovation, tradition make Sanders and Morley Candy Makers a fabulous food plant

Sanders and Morley Candy Makers, which first worked its way into the hearts of those who live in Michigan with factory tours for school kids, is beloved in its home state and is growing nationally.




nova

Fab Food Plant: Tyson’s innovative case-ready meat facility in Eagle Mountain, Utah

Within its walls is one of the most technically advanced food processing plants in the country—a greenfield project built from the ground up with automation, labor savings, sustainability and smart design throughout.





nova

Facility Innovations

For our coverage of Fabulous Food Plants this year, we decided to do something a little bit different in honor of “plants,” aka flora. When we think of food plants, we almost immediately think of processing facilities, but there’s so much more to food production than the processing plant. So, seeing how plant-based foods are altering the ways consumers think about protein, we decided to alter the way we think about food plants.




nova

6 trends shaping consumer product innovation in F&B

Tate & Lyle PLC, a global provider of food and beverage solutions and ingredients, revealed six key trends that are shaping consumer product innovation in the food and beverage market.




nova

Innovations to Take Center Stage in the Oat Milk Market as the Demand for Flavored Drinks Depicts an Increase

The growth of the oat milk market is expected to remain positive in the near future.




nova

Bioenergy Life Science Unveils Innovations at IFT

The company will display its branded ingredients at the show.




nova

Eden Grow Systems Hires Innovation Advisor

Dr. D. Marshall Porterfield will serve in the new role.




nova

Ruiz Foods Eyes Product Innovation and the Contentious Front-of-Pack Ingredient Discussion

At the IFT FIRST Conference, Mimi Bonnett of Innova Market Insights spotlighted the top food trends in the U.S. and Canada, while Michael Warter of Ruiz Foods delivered insights on machine learning and AI.




nova

Tile Industry Gathers in Bologna, Italy, for an Incredible Week of Design, Innovation, and Inspiration.

This year, the exhibition spaces at the show span 15 halls, and th145,000-square-meter exhibition floor hosts 606 exhibitors, including 38% non-Italian companies from 25 different countries. 





nova

Pets Continue to Influence Home Renovation Decisions, Houzz Study Finds

Houzz's 2024 study reveals nearly half of pet owners prioritize their animals when renovating, and flooring was the most popular upgrade.




nova

Participatory children curation: an innovative example.

Children's Geographies; 09/06/2024
(AN 179450400); ISSN: 14733285
Academic Search Premier






nova

Using Legitimation Code Theory to explore knowledge building in English medium higher education teaching: methodological challenges and innovations

Volume 29, Issue 7, October 2024. Read the full article ›

The post Using Legitimation Code Theory to explore knowledge building in English medium higher education teaching: methodological challenges and innovations was curated by information for practice.



  • Journal Article Abstracts

nova

A Bungalow Renovation With Zen Aesthetic in Echo Park

Set in the hills of Echo Park, a bungalow, designed by OWIU, is a serene yet versatile space that integrates natural beauty with modern living.




nova

Brazilian bossa nova pioneer Joao Gilberto dies at 88

Joao Gilberto, a Brazilian singer, guitarist and songwriter considered one of the fathers of the bossa nova genre that gained global popularity in the 1960s and became an iconic sound of the South American nation, died Saturday, his son said. He was 88.




nova

Andrei Rublev won the tournament against Novak Djokovic

Andrei Rublev is one of the Russian tennis players banned from the Wimbledon tournament. He defeated world number one Novak Djokovic in the Serbia Open 2022 final in Belgrade today. Rublev, who is only eighth in the world rankings, beat his opponent 6-2, 6-7 (4-7), 6-0.




nova

Innovative retailers find new uses for RFID to boost their bottom line

A new research report has revealed the innovative new ways retailers are using RFID technology in-store to improve profitability.




nova

Evoke Creative innovates with contactless technology

Wirral-headquartered Evoke Creative, a design-led manufacturer of interactive digital solutions, has developed a series of innovative new products which address the challenges faced by its blue-chip client base as they re-open for customers and employees.




nova

The Retail Technology Show announces the shortlist for its 2024 Innovation Awards

The Retail Technology Show (RTS), the leading industry event that connects retail’s changemakers and leading tech providers, has announced the shortlist of its 2024 Innovation Awards, which champion progressive, best-in-class technologies and solutions.



  • Exhibitions and Events
  • Retail Supply Chain

nova

Avantra showcases AI Innovation and automation leadership at SAP Sapphire Orlando and Barcelona

Avantra, provider of AIOps and automation solutions for SAP environments, was a prominent participant at the recent SAP Sapphire events held in Orlando and Barcelona. The company unveiled its latest AI capabilities and highlighted its pivotal role in enabling organizations to transition from manual operations to advanced automation.




nova

China (Shenzhen) Cross Border E-commerce Fair set to unveil innovation and digital transformation this September

With e-commerce leaders such as Alibaba, Amazon, eBay, and TikTok on hand to share insights at the China (Shenzhen) Cross Border E-commerce Fair (CCBEC) from 11 – 13 September 2024, the show will welcome nearly 1,500 exhibitors from around the globe.




nova

Make the Impossible Possible: Manhattan Showcases Latest Supply Chain Commerce Innovations and Customer Insights at Exchange 2024

Building on the theme, ‘Make the impossible, possible’, Manhattan Associates has opened its annual EMEA Exchange event to an audience of more than 300 customers and press, with keynotes that introduced the European market to Manhattan Active Supply Chain Planning and Generative AI solutions; Manhattan Active Maven and Manhattan Assist.




nova

Penn GSE, the School District of Philadelphia, Foundations, Inc. and the Consortium for Policy Research in Education Partnering to Create an Innovative and Scalable College and Career Readiness Model for Students

The University of Pennsylvania Graduate School of Education (Penn GSE) has been awarded $3.5 million, part of a larger $8 million grant from Education Initiatives, to partner with the School District of Philadelphia (SDP) to launch The Academy at Penn, an innovative five-year, cohort-based college- and career-readiness model for high school students. Foundations, Inc. and the Consortium for Policy Research in Education (CPRE) were also awarded through the grant as part of the larger partnership. The close collaboration involves working together to design, implement, and evaluate the project.




nova

The Lean Impact Start-Up Framework: Fueling Innovation for Positive Societal Change




nova

Angle-resolved X-ray emission spectroscopy facility realized by an innovative spectrometer rotation mechanism at SPring-8 BL07LSU

The X-ray emission spectrometer at SPring-8 BL07LSU has recently been upgraded with advanced modifications that enable the rotation of the spectrometer with respect to the scattering angle. This major upgrade allows the scattering angle to be flexibly changed within the range of 45–135°, which considerably simplifies the measurement of angle-resolved X-ray emission spectroscopy. To accomplish the rotation system, a sophisticated sample chamber and a highly precise spectrometer rotation mechanism have been developed. The sample chamber has a specially designed combination of three rotary stages that can smoothly move the connection flange along the wide scattering angle without breaking the vacuum. In addition, the spectrometer is rotated by sliding on a flat metal surface, ensuring exceptionally high accuracy in rotation and eliminating the need for any further adjustments during rotation. A control system that integrates the sample chamber and rotation mechanism to automate the measurement of angle-resolved X-ray emission spectroscopy has also been developed. This automation substantially streamlines the process of measuring angle-resolved spectra, making it far easier than ever before. Furthermore, the upgraded X-ray emission spectrometer can now also be utilized in diffraction experiments, providing even greater versatility to our research capabilities.




nova

High-throughput and high-resolution powder X-ray diffractometer consisting of six sets of 2D CdTe detectors with variable sample-to-detector distance and innovative automation system

The demand for powder X-ray diffraction analysis continues to increase in a variety of scientific fields, as the excellent beam quality of high-brightness synchrotron light sources enables the acquisition of high-quality measurement data with high intensity and angular resolution. Synchrotron powder diffraction has enabled the rapid measurement of many samples and various in situ/operando experiments in nonambient sample environments. To meet the demands for even higher throughput measurements using high-energy X-rays at SPring-8, a high-throughput and high-resolution powder diffraction system has been developed. This system is combined with six sets of two-dimensional (2D) CdTe detectors for high-energy X-rays, and various automation systems, including a system for automatic switching among large sample environmental equipment, have been developed in the third experimental hutch of the insertion device beamline BL13XU at SPring-8. In this diffractometer system, high-brilliance and high-energy X-rays ranging from 16 to 72 keV are available. The powder diffraction data measured under ambient and various nonambient conditions can be analysed using Rietveld refinement and the pair distribution function. Using the 2D CdTe detectors with variable sample-to-detector distance, three types of scan modes have been established: standard, single-step and high-resolution. A major feature is the ability to measure a whole powder pattern with millisecond resolution. Equally important, this system can measure powder diffraction data with high Q exceeding 30 Å−1 within several tens of seconds. This capability is expected to contribute significantly to new research avenues using machine learning and artificial intelligence by utilizing the large amount of data obtained from high-throughput measurements.




nova

Boston Biotech Announces Novartis Collaboration

Source: Dr. Robert Driscoll 10/28/2024

Monte Rosa Therapeutics Inc. (GLUE:NASDAQ) recently unveiled a collaborative agreement with Novartis for the development of MRT-6160, its VAV1-degrader program, according to a Wedbush research note.

Wedbush analysts Dr. Robert Driscoll, Dr. Ritika Das, and Sam Ravina, in a research report published on October 28, 2024, maintained their Outperform rating on Monte Rosa Therapeutics Inc. (GLUE:NASDAQ) while raising their price target to US$15.00 from US$11.00. The report follows Monte Rosa's announcement of a collaborative agreement with Novartis for the development of MRT-6160, its VAV1-degrader program.

The analysts highlighted the significant financial terms of the agreement, stating, "GLUE will receive an upfront payment of US$150M as well as total milestone payments of up to US$2.1B that will include US$1.5B in potential development and regulatory milestones that begin upon Ph 2 studies."

Regarding the partnership structure, the analysts noted, "Upon start of Ph 3 studies, 30% US P&L would be shared with Ph 3 development co-fund and ex-US tiered royalties. Importantly, NVS will cover the complete costs of Ph 2 studies and will obtain worldwide rights to develop, commercialize and manufacture MRT-6160 as well as other VAV MGDs."

The analysts viewed this collaboration positively, stating, "We view this favorable collaboration agreement as an additional robust validation of GLUE's QuEEN MGD platform (noting Novartis' significant efforts in the degrader space), as well as an acknowledgment of the significant potential opportunities around targeting VAV1 with a first in class degrader."

They also emphasized the strategic benefits, noting, "Furthermore, we note the likely accelerated timelines for the MRT-6160 development program overall, and significant extension of GLUE's operational cash runway, which we expect to allow advancement of its deep pipeline."

The report highlighted the ongoing Phase 1 SAD/MAD healthy subject study for MRT-6160 in autoimmune diseases, with initial data expected in 1Q:25.

Wedbush's valuation methodology is based on sales multiples. The analysts explained, "Our PT is derived from applying a 6x multiple to estimated US sales and a 15x multiple to EU royalties of MRT-2359 in 2031, discounted by 30% annually."

The analysts also outlined several risk factors, including potential clinical and regulatory failure of MRT-2359, challenges in achieving sales estimates, and possible commercial competition from current and future therapies.

In conclusion, Wedbush's increased price target to US$15 reflects growing confidence in Monte Rosa Therapeutics following the Novartis collaboration agreement. The share price at the time of the report of US$8.05 represents a potential return of approximately 86% to the analysts' target price, highlighting the significant upside potential as the company advances its development programs with its new partner.

Sign up for our FREE newsletter at: www.streetwisereports.com/get-news

Important Disclosures:

  1. This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company.
  2. This article does not constitute medical advice. Officers, employees and contributors to Streetwise Reports are not licensed medical professionals. Readers should always contact their healthcare professionals for medical advice.

For additional disclosures, please click here.

Disclosures for Wedbush, Monte Rosa Therapeutics Inc., October 28, 2024

Analyst Certification We, Robert Driscoll, Ritika Das and Sam Ravina, certify that the views expressed in this report accurately reflect our personal opinions and that we have not and will not, directly or indirectly, receive compensation or other payments in connection with our specific recommendations or views contained in this report.

The Distribution of Ratings is required by FINRA rules; however, WS' stock ratings of Outperform, Neutral, and Underperform most closely conform to Buy, Hold, and Sell, respectively. Please note, however, the definitions are not the same as WS' stock ratings are on a relative basis. The analysts responsible for preparing research reports do not receive compensation based on specific investment banking activity. The analysts receive compensation that is based upon various factors including WS' total revenues, a portion of which are generated by WS' investment banking activities. Company Specific Disclosures This information is subject to change at any time. 2. WS managed a public offering of securities for Monte Rosa Therapeutics within the last 12 months. 4. WS has received compensation for investment banking services from Monte Rosa Therapeutics within the last 12 months. 5. WS provided Monte Rosa Therapeutics with investment banking services within the last 12 months.

Wedbush disclosure price charts are updated within the first fifteen days of each new calendar quarter per FINRA regulations. Price charts for companies initiated upon in the current quarter, and rating and target price changes occurring in the current quarter, will not be displayed until the following quarter. Additional information on recommended securities is available on request. Disclosure information regarding historical ratings and price targets is available: Research Disclosures *WS changed its rating system from (Strong Buy/ Buy/ Hold/ Sell) to (Outperform/ Neutral/ Underperform) on July 14, 2009. Applicable disclosure information is also available upon request by contacting the Research Department at (212) 833-1375, by email to leslie.lippai@wedbush.com. You may also submit a written request to the following: Wedbush Securities, Attn: Research Department, 142 W 57th Street, New York, NY 10019.

OTHER DISCLOSURES The information herein is based on sources that we consider reliable, but its accuracy is not guaranteed. The information contained herein is not a representation by this corporation, nor is any recommendation made herein based on any privileged information. This information is not intended to be nor should it be relied upon as a complete record or analysis: neither is it an offer nor a solicitation of an offer to sell or buy any security mentioned herein. This firm, Wedbush Securities, its officers, employees, and members of their families, or any one or more of them, and its discretionary and advisory accounts, may have a position in any security discussed herein or in related securities and may make, from time to time, purchases or sales thereof in the open market or otherwise. The information and expressions of opinion contained herein are subject to change without further notice. The herein mentioned securities may be sold to or bought from customers on a principal basis by this firm. Additional information with respect to the information contained herein may be obtained upon request. Wedbush Securities does and seeks to do business with companies covered in its research reports. Thus, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision. Please see pages 3–7 of this report for analyst certification and important disclosure information. Retail Investors The information provided is for general informational purposes only and should not be considered an individual recommendation or personalized investment advice. The companies/investments mentioned may not be suitable for everyone. Each investor needs to review their own respective situation(s) before making any investment decisions. All expressions of opinion are subject to change without notice due to shifting market(s), economic or political conditions. Investment involves risks including the risk of principal. Past performance is no guarantee of future results and the opinions presented cannot be viewed as an indicator of future performance.

( Companies Mentioned: GLUE:NASDAQ, )